zalcitabine has been researched along with Infections, Hepadnaviridae in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berthillon, P; Cheng, YC; Germon, S; Guerhier, FL; Pichoud, C; Seigneres, B; Trepo, C; Zoulim, F | 1 |
Aldrich, CE; Averett, DR; Cullen, JM; Fourel, I; Mason, WS; Pugh, J; Saputelli, J; Schaffer, P | 1 |
Borel, C; Cheng, YC; Dannaoui, E; Hantz, O; Lin, TS; Liu, SH; Trépo, C; Zoulim, F | 1 |
Gati, WP; Kieller, DM; Rahn, JJ; Tyrrell, DL | 1 |
Chen, SH; Cheng, YC; Chevallier, M; Guerret, S; Hantz, O; Jamard, C; King, I; Le Guerhier, F; Li, XY; Pichoud, C; Trépo, C; Zoulim, F | 1 |
5 other study(ies) available for zalcitabine and Infections, Hepadnaviridae
Article | Year |
---|---|
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Topics: Animals; Disease Models, Animal; Ducks; Hepadnaviridae Infections; Hepatitis; Hepatitis B Virus, Duck; Hepatitis B Virus, Woodchuck; Hepatitis, Viral, Animal; Humans; In Vitro Techniques; Marmota; Reverse Transcriptase Inhibitors; RNA, Viral; Virus Replication; Zalcitabine | 2002 |
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Topics: Animals; Antigens, Viral; Antiviral Agents; Biopsy; Bromodeoxyuridine; Deoxyguanosine; DNA Replication; DNA, Viral; Ducks; Emtricitabine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Kinetics; Liver; Time Factors; Virus Replication; Zalcitabine | 1994 |
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Topics: Animals; Antiviral Agents; Blotting, Southern; Cells, Cultured; DNA Replication; DNA, Viral; Ducks; Female; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Liver; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication; Zalcitabine | 1996 |
Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
Topics: Affinity Labels; Animals; Anti-HIV Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Cells, Cultured; Drug Interactions; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Humans; Thioinosine; Thymidine; Tumor Cells, Cultured; Vidarabine; Zalcitabine | 1997 |
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
Topics: Animals; Antiviral Agents; DNA, Circular; DNA, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Liver; Reverse Transcriptase Inhibitors; Viral Proteins; Virus Replication; Zalcitabine | 2000 |